Clinical Trials: Antihypertensive Agents
- Alfuzosin 48 studies
- Amlodipine, atorvastatin drug combination 15 studies
- Amlodipine, valsartan drug combination 20 studies
- Angiotensin I (1-7) 9 studies
- Benazepril 38 studies
- Bimatoprost 71 studies
- Bosentan 78 studies
- BQ 788 3 studies
- Brimonidine 77 studies
- Candesartan 98 studies
- Candesartan cilexetil 98 studies
- Carvedilol 103 studies
- Cycletanide 1 study
- Cyclo(Trp-Asp-Pro-Val-Leu) 11 studies
- Dorzolamide 47 studies
- Eprosartan 5 studies
- Essential 303 forte 1 study
- Ferulic acid 1 study
- Hydrochlorothiazide, lisinopril drug combination 1 study
- Imidapril 3 studies
- Indapamide, perindopril drug combination 2 studies
- Irbesartan 75 studies
- Isopropyl unoprostone 1 study
- Lacidipine 4 studies
- Latanoprost 148 studies
- Lercanidipine 9 studies
- Lofexidine 12 studies
- Manidipine 3 studies
- Moxonidine 10 studies
- N(1),N(11)-diethylnorspermine 2 studies
- N(1),N(14)-bis(ethyl)homospermine 1 study
- Naftopidil 2 studies
- Nebivolol 63 studies
- Olmesartan medoxomil 85 studies
- Quinapril 21 studies
- Rilmenidine 1 study
- Terlipressin 23 studies
- Tibolone 19 studies
- Tocopherylquinone 2 studies
- Torsemide 11 studies
- Trandolapril 18 studies
- Travoprost 91 studies
- Treprostinil 46 studies
- Urapidil 6 studies
- Valsartan 202 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://www.clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_AnAg
